|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5805 USD | +0.09% |
|
+2.42% | +0.07% |
| Dec. 18 | RTW Biotech Opportunities announces new investment in Yarrow Bioscience | RE |
| Dec. 17 | VYNE Therapeutics Inc., Yarrow Bioscience, Inc. - M&A Call |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 0.6 | 0.6473 | 0.89 |
| Spread/Res. | -3.25% | -10.32% | -34.78% |
| Spread/Supp. | +24.89% | +102.26% | +94.02% |
| Support | 0.4648 | 0.287 | 0.2992 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- VYNE Stock
- Charts VYNE Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
